ZimVie to be acquired by ARCHIMED for $19.00/share in cash; enterprise value ~$730M

ZimVie Inc.

Enterprise value of ~$730M; ZimVie stockholders to receive $19.00 per share in cash.
Premium of 99% to 90-day volume-weighted average price of $9.57 per share.
Transaction expected to close by year-end 2025; subject to stockholder vote and regulatory approvals.
ZimVie may solicit alternative proposals during a 40-day go-shop period ending Aug 29, 2025.
Board unanimously approved; transaction not subject to financing condition; NASDAQ delisting upon close.

item 1.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.